Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The method accurately measures hormones and endocannabinoids in mice, showing gut microbiota diversity affects these levels and may influence stress and reproductive systems.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Probe detects finasteride with high selectivity and low detection limit.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

New compounds may soon be tested to treat excessive hair growth in women.

Finasteride affects prostate weights and pituitary activity differently with age.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.